← Leaderboards
Bradley T Hyman
Massachusetts General Hospital
$51,936,441
Attributed
$64,714,446
Total exposure
33
Grants
23
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $10.6M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$111,711,436 · 35
By mechanism
P50$40,799,289 · 9
P30$24,123,338 · 3
R01$21,404,265 · 6
RF1$11,507,239 · 4
R37$4,716,276 · 1
R56$4,377,622 · 3
Top collaborators
- Rudolf Jaenisch5 shared
- Manolis Kellis5 shared
- Li-Huei Tsai5 shared
- Christine S Ritchie3 shared
- Dudley K. Strickland3 shared
- Jatin M Vyas3 shared
- Michael Jackson2 shared
- Mahlon Collins1 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Jatin M Vyas$17,714,264
- Rakesh K. Jain$48,476,214
- Steven Kyle Grinspoon$75,757,679
- Joseph El-Khoury$13,402,382
- Edward A Stern$1,074,975
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseProgramsDementiaResearch PersonnelPhenotypeMassachusettsNeuropathologyNeurofibrillary TanglesLaboratoriesNeuronsLeadCollaborationsFunctional DisorderImageStructureBrainFutureBaseResourcesRelating To Nervous SystemEnvironmentCommunitiesMission
Grant awards (161)
Comprehensive and Cell Type-Specific Proteogenomic Profiling of Aberrant and Mis-Processed Proteins in Alzheimer's Disease and Tauopathy Models$784,596
R01 · FY2025 · AG
LRP1-tau interactions and Alzheimer Disease$776,835
R01 · FY2025 · AG
MGH Diseases of Aging Pathway Via Stimulating Access to Research in Residency (MGH DAP StARR)$268,680
R38 · FY2025 · AG
Discovery and development of apoE4 correctors for the treatment of Alzheimer's disease$881,443
R56 · FY2024 · AG
LRP1-tau interactions and Alzheimer Disease$792,690
R01 · FY2024 · AG
MGH Diseases of Aging Pathway Via Stimulating Access to Research in Residency (MGH DAP StARR)$268,680
R38 · FY2024 · AG
Massachusetts Alzheimer's Disease Research Center$3,306,700
P30 · FY2023 · AG · contact PI
Administrative Core$1,443,224
P30 · FY2023 · AG · contact PI
Discovery and development of apoE4 correctors for the treatment of Alzheimer's disease$919,106
R56 · FY2023 · AG
MGH Diseases of Aging Pathway Via Stimulating Access to Research in Residency (MGH DAP StARR)$268,680
R38 · FY2023 · AG
Massachusetts Alzheimer's Disease Research Center$65,016
P30 · FY2023 · AG · contact PI
Massachusetts Alzheimer's Disease Research Center$3,306,700
P30 · FY2022 · AG · contact PI
Administrative Core$1,192,122
P30 · FY2022 · AG · contact PI
Massachusetts Alzheimer's Disease Research Center$86,688
P30 · FY2022 · AG · contact PI
Massachusetts Alzheimer's Disease Research Center$50,416
P30 · FY2022 · AG · contact PI
Massachusetts Alzheimer's Disease Research Center P30 Diversity Supplement Gaona$21,672
P30 · FY2022 · AG · contact PI
Massachusetts Alzheimer's Disease Research Center$3,361,193
P30 · FY2021 · AG · contact PI
LRP1-tau interactions and Alzheimer Disease$2,384,270
RF1 · FY2021 · AG
Epigenomic, transcriptional and cellular dissection of Alzheimer's variants$1,552,886
R01 · FY2021 · AG
Administrative Core$1,183,519
P30 · FY2021 · AG · contact PI
Massachusetts Alzheimer's Disease Research Center$59,352
P30 · FY2021 · AG · contact PI
Massachusetts Alzheimer's Disease Research Center$3,486,460
P30 · FY2020 · AG · contact PI
Multi-omic Brain Cell Atlas of Alzheimer's Disease Progression$1,923,515
R56 · FY2020 · AG
Epigenomic, transcriptional and cellular dissection of Alzheimer's variants$1,578,214
R01 · FY2020 · AG
Administrative Core$1,004,900
P30 · FY2020 · AG · contact PI
Liquid liquid phase separation and tau biology$204,184
R21 · FY2020 · AG · contact PI
Massachusetts Alzheimer's Disease Research Center$48,680
P30 · FY2020 · AG · contact PI
Novel Strategies and Mechanisms to Target APOE and Alzheimer's Disease$3,760,149
RF1 · FY2019 · AG
Massachusetts Alzheimer's Disease Research Center$3,298,540
P30 · FY2019 · AG · contact PI
Epigenomic, transcriptional and cellular dissection of Alzheimer's variants$1,610,182
R01 · FY2019 · AG
Administrative Core$953,066
P30 · FY2019 · AG · contact PI
Complexity and Heterogeneity of Alzheimer disease$653,558
R56 · FY2019 · AG · contact PI
Liquid liquid phase separation and tau biology$246,184
R21 · FY2019 · AG · contact PI
Massachusetts Alzheimer's Disease Research Center$104,861
P30 · FY2019 · AG · contact PI
Are multiple tau species toxic in Alzheimer's Disease?$2,738,635
RF1 · FY2018 · AG · contact PI
Massachusetts Alzheimer's Disease Research Center$2,717,750
P50 · FY2018 · AG · contact PI
Synergy between amyloid and tau in Alzheimer's Disease$2,624,185
RF1 · FY2018 · AG · contact PI
Epigenomic, transcriptional and cellular dissection of Alzheimer's variants$1,642,247
R01 · FY2018 · AG
Core A: Administrative Core$525,952
P50 · FY2018 · AG · contact PI
Mouse Model of Early Alzheimer's Disease$207,535
P50 · FY2018 · AG · contact PI
Massachusetts Alzheimer's Disease Research Center$2,895,590
P50 · FY2017 · AG · contact PI
Epigenomic, transcriptional and cellular dissection of Alzheimer's variants$1,527,396
R01 · FY2017 · AG
Core A: Administrative Core$560,124
P50 · FY2017 · AG · contact PI
Mouse Model of Early Alzheimer's Disease$222,281
P50 · FY2017 · AG · contact PI
Massachusetts Alzheimer's Disease Research Center$201,352
P50 · FY2017 · AG · contact PI
Massachusetts Alzheimer's Disease Research Center$171,000
P50 · FY2017 · AG · contact PI
Massachusetts Alzheimer's Disease Research Center$2,717,750
P50 · FY2016 · AG · contact PI
Core A: Administrative Core$525,725
P50 · FY2016 · AG · contact PI
Mouse Model of Early Alzheimer's Disease$208,619
P50 · FY2016 · AG · contact PI
Massachusetts Alzheimer's Disease Research Center$195,601
P50 · FY2016 · AG · contact PI
Massachusetts Alzheimer's Disease Research Center$177,840
P50 · FY2016 · AG · contact PI
Massachusetts Alzheimer's Disease Research Center$2,636,217
P50 · FY2015 · AG · contact PI
Core A: Administrative Core$509,954
P50 · FY2015 · AG · contact PI
Calcineurin-mediated neurodegeneration in Alzheimer Disease$375,829
R01 · FY2015 · AG · contact PI
Mouse Model of Early Alzheimer's Disease$202,359
P50 · FY2015 · AG · contact PI
Massachusetts Alzheimer's Disease Research Center$200,000
P50 · FY2015 · AG · contact PI
Massachusetts Alzheimer's Disease Research Center$2,717,750
P50 · FY2014 · AG · contact PI
Core A: Administrative Core$525,725
P50 · FY2014 · AG · contact PI
Anatomical Changes in Tau Transgenic Models$436,688
R01 · FY2014 · AG · contact PI
Calcineurin-mediated neurodegeneration in Alzheimer Disease$400,289
R01 · FY2014 · AG · contact PI
Center for Alzheimer Therapeutic Science: CATS$348,000
R34 · FY2014 · AG · contact PI
Mouse Model of Early Alzheimer's Disease$208,619
P50 · FY2014 · AG · contact PI
Massachusetts Alzheimer's Disease Research Center$1,807,184
P50 · FY2013 · AG · contact PI
Anatomical Changes in Tau Transgenic Models$412,676
R01 · FY2013 · AG · contact PI
Calcineurin-mediated neurodegeneration in Alzheimer Disease$390,562
R01 · FY2013 · AG · contact PI
ADMINISTRATIVE$280,831
P50 · FY2013 · AG · contact PI
NEUROPATHOLOGICAL CORRELATES OF OLIGOMERIC AMYLOID BETA$196,437
P50 · FY2013 · AG · contact PI
Massachusetts Alzheimer's Disease Research Center$1,945,499
P50 · FY2012 · AG · contact PI
Anatomical Changes in Tau Transgenic Models$436,700
R01 · FY2012 · AG · contact PI
Calcineurin-mediated neurodegeneration in Alzheimer Disease$426,779
R01 · FY2012 · AG · contact PI
ADMINISTRATIVE$328,538
P50 · FY2012 · AG · contact PI
NEUROPATHOLOGICAL CORRELATES OF OLIGOMERIC AMYLOID BETA$227,554
P50 · FY2012 · AG · contact PI
A Model of Early Alzheimer Disease$214,553
R21 · FY2012 · AG · contact PI
Massachusetts Alzheimer's Disease Research Center$1,958,134
P50 · FY2011 · AG · contact PI
Calcineurin-mediated neurodegeneration in Alzheimer Disease$441,480
R01 · FY2011 · AG · contact PI
Anatomical Changes in Tau Transgenic Models$436,695
R01 · FY2011 · AG · contact PI
ADMINISTRATIVE$310,809
P50 · FY2011 · AG · contact PI
NEUROPATHOLOGICAL CORRELATES OF OLIGOMERIC AMYLOID BETA$213,070
P50 · FY2011 · AG · contact PI
A Model of Early Alzheimer Disease$178,268
R21 · FY2011 · AG · contact PI
Peripherally administered gene therapy for Alzheimer's$49,952
RC1 · FY2011 · AG · contact PI
LRP AND ALZHEIMER'S DISEASE$10,000
R37 · FY2011 · AG · contact PI
Massachusetts Alzheimer's Disease Research Center$1,992,629
P50 · FY2010 · AG · contact PI
Faculty recruitment for programs in the biology of age-related cognitive change$575,250
P30 · FY2010 · AG · contact PI
Neurologic Alterations in Alzheimer's Disease$542,628
R01 · FY2010 · AG · contact PI
Peripherally administered gene therapy for Alzheimer's$489,562
RC1 · FY2010 · AG · contact PI
Anatomical Changes in Tau Transgenic Models$459,159
R01 · FY2010 · AG · contact PI
ADMINISTRATIVE$319,526
P50 · FY2010 · AG · contact PI
NEUROPATHOLOGICAL CORRELATES OF OLIGOMERIC AMYLOID BETA$216,792
P50 · FY2010 · AG · contact PI
Anatomical changes in tau trangenic models$74,238
R01 · FY2010 · AG · contact PI
Massachusetts Alzheimer's Disease Research Center$1,989,373
P50 · FY2009 · AG · contact PI
Faculty recruitment for programs in the biology of age-related cognitive change$574,979
P30 · FY2009 · AG · contact PI
Neurologic Alterations in Alzheimer's Disease$532,149
R01 · FY2009 · AG · contact PI
Peripherally administered gene therapy for Alzheimer's$499,848
RC1 · FY2009 · AG · contact PI
LRP AND ALZHEIMER'S DISEASE$449,157
R37 · FY2009 · AG · contact PI
ADMINISTRATIVE$316,975
P50 · FY2009 · AG · contact PI
NEUROPATHOLOGICAL CORRELATES OF OLIGOMERIC AMYLOID BETA$231,075
P50 · FY2009 · AG · contact PI
Neurologic Alterations in Alzheimer's Disease$70,276
R01 · FY2009 · AG · contact PI
LRP AND ALZHEIMER'S DISEASE$10,000
R37 · FY2009 · AG · contact PI
Massachusetts Alzheimer's Disease Research Center$1,781,675
P50 · FY2008 · AG · contact PI
Neurologic Alterations in Alzheimer's Disease$516,646
R01 · FY2008 · AG · contact PI
LRP AND ALZHEIMER'S DISEASE$436,075
R37 · FY2008 · AG · contact PI
Molecular Chaperones in Lewy Body Diseases$357,237
P50 · FY2008 · NS · contact PI
TAU ALTERATIONS IN ALZHEIMER'S AND RELATED DEMENTIAS$338,459
P50 · FY2008 · AG · contact PI
Anatomical changes in tau trangenic models$282,602
R01 · FY2008 · AG · contact PI
Core--Scientific$252,840
P01 · FY2008 · NS · contact PI
LRP AND ALZHEIMER'S DISEASE$5,000
R37 · FY2008 · AG · contact PI
Massachusetts Alzheimer's Disease Research Center$1,776,429
P50 · FY2007 · AG · contact PI
Neurologic Alterations in Alzheimer's Disease$511,835
R01 · FY2007 · AG · contact PI
GAMMA SECRETASE AND SUBSTRATE INTERACTIONS$470,135
P01 · FY2007 · AG · contact PI
Molecular Chaperones in Lewy Body Diseases$432,260
P50 · FY2007 · NS · contact PI
LRP AND ALZHEIMER'S DISEASE$432,017
R37 · FY2007 · AG · contact PI
TAU ALTERATIONS IN ALZHEIMER'S AND RELATED DEMENTIAS$380,859
P50 · FY2007 · AG · contact PI
Anatomical changes in tau trangenic models$279,973
R01 · FY2007 · AG · contact PI
Core--Scientific$259,026
P50 · FY2007 · NS · contact PI
Massachusetts Alzheimer's Disease Research Center$126,000
P50 · FY2007 · AG · contact PI
Massachusetts Alzheimer's Disease Research Center$1,792,939
P50 · FY2006 · AG · contact PI
Neurologic Alterations in Alzheimer's Disease$511,768
R01 · FY2006 · AG · contact PI
LRP AND ALZHEIMER'S DISEASE$431,959
R37 · FY2006 · AG · contact PI
GAMMA SECRETASE AND SUBSTRATE INTERACTIONS$406,451
P01 · FY2006 · AG · contact PI
Molecular Chaperones in Lewy Body Diseases$367,500
P50 · FY2006 · NS · contact PI
Anatomical changes in tau trangenic models$279,932
R01 · FY2006 · AG · contact PI
Core--Scientific$242,377
P50 · FY2006 · NS · contact PI
TAU ALTERATIONS IN ALZHEIMER'S AND RELATED DEMENTIAS$230,589
P50 · FY2006 · AG · contact PI
CORE--NEUROPATHOLOGY$90,674
P01 · FY2006 · AG · contact PI
Neuroanatomical Alterations in Alzheimer's Disease$562,266
R01 · FY2005 · AG
LRP AND ALZHEIMER'S DISEASE$448,219
R37 · FY2005 · AG
Molecular Chaperones in Lewy Body Diseases$367,500
P50 · FY2005 · NS
Anatomical changes in tau trangenic models$278,320
R01 · FY2005 · AG
Core--Scientific$237,127
P50 · FY2005 · NS
TAU ALTERATIONS IN ALZHEIMER'S AND RELATED DEMENTIAS$225,010
P50 · FY2005 · AG
Neuroanatomical Alterations in Alzheimer's Disease$547,436
R01 · FY2004 · AG
LRP AND ALZHEIMER'S DISEASE$492,699
R37 · FY2004 · AG
Molecular Chaperones in Lewy Body Diseases$367,325
P50 · FY2004 · NS
Anatomical changes in tau trangenic models$288,699
R01 · FY2004 · AG
Core--Scientific$238,002
P50 · FY2004 · NS
TAU ALTERATIONS IN ALZHEIMER'S AND RELATED DEMENTIAS$218,339
P50 · FY2004 · AG
Neuroanatomical Alterations in Alzheimer's Disease$533,040
R01 · FY2003 · AG
LRP AND ALZHEIMER'S DISEASE$478,702
R37 · FY2003 · AG
LRP AND ALZHEIMER'S DISEASE$145,500
R37 · FY2003 · AG
Neuroanatomical Alterations in Alzheimer's Disease$574,062
R01 · FY2002 · AG
LRP AND ALZHEIMER'S DISEASE$467,010
R37 · FY2002 · AG
CORE--NEUROPATHOLOGY$80,560
P01 · FY2002 · AG
Neuroanatomical Alterations in Alzheimer's Disease$31,000
R01 · FY2002 · AG
ROLE OF ALPHA SYNUCLEIN IN LEWY BODY DISEASE$0
P50 · FY2002 · NS
APOE AND TRANSGENIC MODELS OF ALZHEIMERS DISEASE$0
P50 · FY2002 · AG
APOE AND TRANSGENIC MODELS OF ALZHEIMERS DISEASE$0
P50 · FY2002 · AG
GENETIC MODIFIERS OF AMYLOID BETA DEPOSITION--NEUROANATOMIC CORRELATES$0
P01 · FY2002 · AG
TRANSGENICS AND PRESENILIN FUNCTION$0
P01 · FY2002 · AG
Neuroanatomical Alterations in Alzheimer's Disease$505,492
R01 · FY2001 · AG
LRP AND ALZHEIMER'S DISEASE$454,724
R37 · FY2001 · AG
ROLE OF ALPHA SYNUCLEIN IN LEWY BODY DISEASE$0
P50 · FY2001 · NS
ROLE OF ALPHA SYNUCLEIN IN LEWY BODY DISEASE$0
P50 · FY2001 · NS
APOE AND TRANSGENIC MODELS OF ALZHEIMERS DISEASE$0
P50 · FY2001 · AG
GENETIC MODIFIERS OF AMYLOID BETA DEPOSITION--NEUROANATOMIC CORRELATES$0
P01 · FY2001 · AG
TRANSGENICS AND PRESENILIN FUNCTION$0
P01 · FY2001 · AG
LRP AND ALZHEIMER'S DISEASE$455,214
R37 · FY2000 · AG
APOE AND TRANSGENIC MODELS OF ALZHEIMERS DISEASE$277,299
P50 · FY2000 · AG
TRANSGENICS AND PRESENILIN FUNCTION$223,701
P01 · FY2000 · AG
GENETIC MODIFIERS OF AMYLOID BETA DEPOSITION--NEUROANATOMIC CORRELATES$222,455
P01 · FY2000 · AG
ROLE OF ALPHA SYNUCLEIN IN LEWY BODY DISEASE$121,168
P50 · FY2000 · NS
APOE AND TRANSGENIC MODELS OF ALZHEIMERS DISEASE$0
P50 · FY2000 · AG